06.01.2020 Views

Open Access e-Journal Cardiometry - No.15 November 2019

We have decided to dedicate this issue to discussing sports medicine topics, namely, to defining what is the healthy heart performance. We are glad to present some fresh papers considering these problems of physiology in sports from the standpoint of cardiometry: the material is an integral part of a new book, which will be published within the nearest future.

We have decided to dedicate this issue to discussing sports medicine topics, namely, to defining what is the healthy heart performance. We are glad to present some fresh papers considering these problems of physiology in sports from the standpoint of cardiometry: the material is an integral part of a new book, which will be published within the nearest future.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

STR. They concluded that higher NLR at the time of

admission in patients with acute myocardial infarction

undergoing primary coronary intervention is

correlated with coronary no reflow phenomenon and

poor long term prognosis. The results of their study

matches our results as well (10).

Conclusion

In our study we evaluated the relationship between

neutrophil count, lymphocyte count, NLR, RDW,

PDW and RPR with STR. There was only a significant

correlation between NLR and STR. NLR was significantly

lower in patients with STR>70%.

On the other hand, there was a significant relationship

observed between all mentioned indexed except

RDW and PDW with 2 month complications.

It can be concluded that it is possible to use NLR

and RPR to predict STR and short term complications

in patients with acute myocardial infarction undergoing

primary coronary intervention.

Based on our results, it seems that applying mentioned

cheap, fast and accessible markers along with

other prognostic markers and clinical conditions in

daily practice, can be helpful in prognosis prediction

and choosing the best treatment strategy (using anti-inflammatory

agents such as Canakinumab) in future

to prevent recurrence of acute coronary infarction

(56,63).

Statement on ethical issues

Research involving people and/or animals is in full

compliance with current national and international

ethical standards.

Conflict of interest

None declared.

Author contributions

The authors read the ICMJE criteria for authorship

and approved the final manuscript.

References

1. Buchanan GL, Chieffo A, Colombo A. Is there still a

survival advantage to bypass surgery over percutaneous

intervention in the modern era? Progress in cardiovascular

diseases. 2015;58(3):335-41.

2. Schwartz BG, Kloner RA. Coronary no reflow.

Journal of molecular and cellular cardiology. 2012;

52(4):873-82.

3. Oncel RC, Ucar M, Karakas MS, Akdemir B,

Yanikoglu A, Gulcan AR, et al. Relation of neutrophil-to-lymphocyte

ratio with GRACE risk score to

in-hospital cardiac events in patients with ST-segment

elevated myocardial infarction. Clinical and Applied

Thrombosis/Hemostasis. 2015;21(4):383-8.

4. Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik

T, et al. Relation of neutrophil/lymphocyte ratio

to coronary flow to in-hospital major adverse cardiac

events in patients with ST-elevated myocardial infarction

undergoing primary coronary intervention. The

American journal of cardiology. 2012;110(5):621-7.

5. Cho KH, Jeong MH, Ahmed K, Hachinohe D, Choi

HS, Chang SY, et al. Value of early risk stratification using

hemoglobin level and neutrophil-to-lymphocyte ratio in

patients with ST-elevation myocardial infarction undergoing

primary percutaneous coronary intervention. The

American journal of cardiology. 2011;107(6):849-56.

6. Park JJ, Jang H-J, Oh I-Y, Yoon C-H, Suh J-W, Cho

Y-S, et al. Prognostic value of neutrophil to lymphocyte

ratio in patients presenting with ST-elevation

myocardial infarction undergoing primary percutaneous

coronary intervention. The American journal

of cardiology. 2013;111(5):636-42.

7. Pellizzon GG, Dixon SR, Stone GW, Cox DA. Relation

of admission white blood cell count to longterm

outcomes after primary coronary angioplasty for

acute myocardial infarction (The Stent PAMI Trial).

The American journal of cardiology. 2003;91(6):729-.

8. Furman MI, Gore JM, Anderson FA, Budaj A,

Goodman SG, Avezum Á, et al. Elevated leukocyte

count and adverse hospital events in patients with

acute coronary syndromes: findings from the Global

Registry of Acute Coronary Events (GRACE). American

heart journal. 2004;147(1):42-8.

9. Uğur M, Ayhan E, Bozbay M, Çiçek G, Ergelen M,

Işık T, et al. The independent association of plateletcrit

with long-term outcomes in patients undergoing

primary percutaneous coronary intervention. Journal

of critical care. 2014;29(6):978-81.

10. Sen N, Afsar B, Ozcan F, Buyukkaya E, Isleyen A,

Akcay AB, et al. The neutrophil to lymphocyte ratio

was associated with impaired myocardial perfusion and

long term adverse outcome in patients with ST-elevated

myocardial infarction undergoing primary coronary

intervention. Atherosclerosis. 2013;228(1):203-10.

11. Varastehravan H, Naghedi A, Nough H, Pourmirafzali

H. The relationship between severity of coronary

artery disease and mean platelet volume2019.

54 | Cardiometry | Issue 15. November 2019

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!